Anti-Idiotype Antibodies | Drug Monitoring & ADA Assays

Access anti-idiotype antibodies specifically targeting the variable regions of approved therapeutic antibodies. Essential reagents for pharmacokinetic (PK) drug quantification and anti-drug antibody (ADA) immunogenicity assessment in preclinical and clinical sample analysis. All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO

Why Researchers Choose abinScience

Therapeutic-Specific Targeting Each anti-idiotype antibody recognizes the unique CDR region of a specific therapeutic — enabling selective detection in the presence of endogenous immunoglobulins.

ADA & PK Assay Ready Serves as capture and detection reagents in PK bridging ELISA, and as positive controls for ADA immunogenicity assay validation.

Broad Therapeutic Coverage Anti-ID antibodies available for adalimumab, trastuzumab, pembrolizumab, nivolumab, rituximab, bevacizumab, atezolizumab, and many more approved drugs.

Paired with Biosimilars Use together with our research biosimilar antibodies for complete ADA/PK assay development — anti-ID for detection, biosimilar as calibrator.